Luseogliflozin

Luseogliflozin (pronounced loo-see-oh-gli-floh-zin) is a type of antidiabetic drug specifically classified as a Sodium-glucose cotransporter 2 (SGLT2) inhibitor. It is used in the treatment of Type 2 diabetes.

Etymology

The name "Luseogliflozin" is derived from the class of drugs it belongs to, the SGLT2 inhibitors. The "-gliflozin" suffix is common to all drugs in this class.

Pharmacology

Luseogliflozin works by inhibiting the SGLT2 protein, which is responsible for reabsorbing glucose in the kidneys. By inhibiting this protein, Luseogliflozin causes excess glucose to be excreted in the urine, thereby lowering blood glucose levels.

Related Terms

• SGLT2 inhibitors
• Type 2 diabetes
• Antidiabetic drug
• Glucose
• Kidneys

See Also

• Canagliflozin
• Dapagliflozin
• Empagliflozin

External links

• Medical encyclopedia article on Luseogliflozin
• Wikipedia's article - Luseogliflozin

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski